AGONIST INDUCED CA2+ SIGNALING IN MESENCHYMAL STROMAL CELLS
Abstract and keywords
Abstract (English):
Mesenchymal stromal cells (MSCs) from different sources represent a heterogeneous population of proliferating non-differentiated cells that contains multipotent stem cells capable of originating a variety of mesenchymal cell lineages. By using Ca2+ imaging and the Ca2+ dye Fluo-4, we studied MSCs from the human adipose tissue and examined Ca2+ signaling initiated by purinergic agonists. Although all tested compounds were capable of mobilizing intracellular Ca2+ in MSCs, sensitivity of individual MSCs to a particular agonist varied from cell to cell. Being characterized by a relative change of Fluo-4 fluorescence, agonist-induced Ca2+ responses were generated in an “all-or-nothing” fashion. Specifically, at relatively low doses, agonists elicited undetectable responses but initiated quite similar Ca2+ transients of large magnitude at all concentrations above the threshold, which was nearly 0.1, 0.2, 0.5, 1, and 2 µM for noradrenaline, ADP, ATP, and UTP, respectively. The inhibitory analysis and Ca2+/IP3 uncaging pointed at the phosphoinositide cascade as a pivotal pathway responsible for agonist transduction and implicated Ca2+-induced Ca2+ release (CICR) mediated by IP3 receptors in shaping agonists-dependent Ca2+ signals. Altogether, our data suggest that agonist transduction in MSCs includes two fundamentally different stages: an agonist initially triggers a local, gradual, and relatively small Ca2+ signal, which next stimulates CICR to accomplish transduction with a large and global Ca2+ transient. By involving the trigger-like mechanism CICR, a cell is capable of generating Ca2+ responses of virtually universal shape and magnitude at different agonist concentrations above the threshold.

Keywords:
Ca2+ signaling, G-protein coupled receptors, calcium-induced calcium release, IP3 receptors, mesenchymal stromal cells
Text
Publication text (PDF): Read Download
References

1. Kalinina N.I., Sysoeva V.Y., Rubina K.A., Parfenova Y.V., Tkachuk V.A. Mesenchymal stem cells in tissue growth and repair. Acta Naturae, 2011, vol. 3. pp. 30-37.

2. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell, 2012, vol. 10. pp. 709-716.

3. Baer P.C., Geiger H. Adipose-Derived Mesenchymal Stromal/StemCells: Tissue Localization, Characterization, and Heterogeneity. Stem Cells International, 2012, 812693.

4. Casiraghi F., Perico N., Cortinovis M., Remuzzi G. Mesenchymal stromal cells in renal transplantation: opportunities and challenges. Nature Reviews. Nephrology, 2016, vol. 12, pp. 241-253.

5. Scarfi S. Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions. World Journal of Stem Cells, 2014, vol. 6, pp. 153-162.

6. Forostyak O., Forostyak S., Kortus S., Sykova E., Verkhratsky A., Dayanithi G. Physiology of Ca2+ signalling in stem cells of different origins and differentiation stages. Cell Calcium, 2016, vol. 59, pp. 57-66.

7. Penicaud L. Relationships between adipose tissues and brain: what do we learn from animal studies? Diabet and Metabolism, 2010, vol. 36, pp. 39-44.

8. Cavaliere F., Donno C., D'Ambrosi N. Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation. Frontiers in Cellular Neuroscience, 2015, vol. 9, p. 211.

9. Glaser T., Cappellari A.R., Pillat M.M., Iser I.C., Wink M.R., Battastini A.M., Ulrich H. Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration. Purinergic Signal, 2012, vol. 8, pp. 523-537.

10. Jiang L.H., Hao Y., Mousawi F., Peng H., Yang X. Expression of P2 Purinergic Receptors in Mesenchymal Stem Cells and Their Roles in Extracellular Nucleotide Regulation of Cell Functions. Journal of Cellular Physiology, 2017, vol. 232, pp. 287-297.

11. Zimmermann H., Zebisch M., Strater N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signaling, 2012, vol. 8, pp. 437-502.

12. Burnstock G. Purinergic signalling: from discovery to current developments. Experimental Physiology, 2014, vol. 99, pp. 16-34.

13. Kotova P.D., Sysoeva V.Y., Rogachevskaja O.A., Bystrova M.F., Kolesnikova A.S., Tyurin-Kuzmin P.A., Fadeeva J.I., Tkachuk V.A., Kolesnikov S.S. Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue. Biochimica et Biophysica Acta, 2014, vol. 1843, pp. 1899-1908.

14. Berridge M.J. The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease. Physiological Reviews, 2016, vol. 96, pp. 1261-1296.

15. Samways D.S., Li Z., Egan T.M. Principles and properties of ion flow in P2X receptors. Frontiers in Cellular Neuroscience, 2014, vol. 8, p. 6.

16. Xu S.Z., Zeng F., Boulay G., Grimm C., Harteneck C., Beech D.J. Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. British Journal of Pharmacology, 2005, vol. 145, pp. 405-414.

17. Mustafa T., Walsh J., Grimaldi M., Eiden L.E. PAC1hop receptor activation facilitates catecholamine secretion selectively through 2-APB-sensitive Ca2+ channels in PC12 cells. Cellular Signaling, 2010, vol. 22, pp. 1420-1426.

18. Harteneck C., Gollasch M. Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channels. Current Pharmaceutical Biotechnology, 2011, vol. 12, pp. 35-41.

19. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signaling: Dynamics, homeostasis and remodeling. Nature Reviews. Molecular Cell Biology, 2003, vol. 4, pp. 517-529.

20. Berg K.A., Clarke W.P., Sailstad C., Saltzman A., Maayani S. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Molecular Pharmacology, 1994, vol. 46, pp. 477-484.

21. Baryshnikov S.G., Rogachevskaja O.A., Kolesnikov S.S. Calcium signaling mediated by P2Y receptors in mouse taste cells. Journal of Neurophysiology, 2003, vol. 90, pp. 3283-3294.

22. Petrel C., Kessler A., Dauban P., Dodd R.H., Rognan D., Ruat M. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. The Journal of Biological Chemistry, 2004, vol. 279, pp. 18990-18997.

23. Clapham D.E. Calcium Signaling. Cell, 2007, vol. 131, pp. 1047-1058.

24. Iino M. Spatiotemporal dynamics of Ca2+ signaling and its physiological roles. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 2010, vol. 86, pp. 244-256.


Login or Create
* Forgot password?